Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Aimed at Comparing Activated Partial Thromboplastin Time and Anti-Xa Activity and in Patients Requiring Unfractionated Heparin Infusion

NCT03426982 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.

NCT NCT03426982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03426982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Aimed at Comparing Activated Partial Thromboplastin Time and Anti-Xa Activity and in Patients Requiring Unfractionated Heparin Infusion
Lead sponsor
Wuhan Asia Heart Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2018
Completion date
October 30, 2018
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, myocardial infarction, stroke, venous thromboembolism